PCM
AMED
Pentwater Capital Management’s Amedisys AMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169M | Buy |
1,715,084
+370,084
| +28% | +$36.4M | 1.09% | 13 |
|
|
2025
Q1 | $125M | Buy |
1,345,000
+165,000
| +14% | +$15.3M | 1.05% | 15 |
|
|
2024
Q4 | $107M | Buy |
1,180,000
+105,000
| +10% | +$9.53M | 1.18% | 12 |
|
|
2024
Q3 | $104M | Buy |
1,075,000
+293,741
| +38% | +$28.3M | 1.07% | 13 |
|
|
2024
Q2 | $71.7M | Buy |
781,259
+141,259
| +22% | +$13M | 0.92% | 16 |
|
|
2024
Q1 | $59M | Sell |
640,000
-140,000
| -18% | -$12.9M | 0.6% | 17 |
|
|
2023
Q4 | $74.1M | Sell |
780,000
-364,000
| -32% | -$34.6M | 0.83% | 17 |
|
|
2023
Q3 | $107M | Buy |
1,144,000
+807,000
| +239% | +$75.4M | 0.57% | 12 |
|
|
2023
Q2 | $30.8M | Buy |
+337,000
| New | +$30.8M | 0.21% | 27 |
|